Tecentriq Takes EU Lead In Triple-Negative Breast Cancer

 
• By John Davis
  
Cycling
Roche is ahead of the field in triple-negative breast cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer